Skip to content

Author

G. Bisogno

We have 1 of 49 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Maintenance therapy with low dose cyclophosphamide does not increase the risk of second malignancies: The European Pediatric Soft Tissue Sarcoma Study Group RMS2005 study experience

The addition of maintenance chemotherapy with low‐dose cyclophosphamide and vinorelbine has improved survival outcomes for patients with high‐risk disease, but the potential SMN risk from increased cumulative alkylating agent exposure remains unclear.

G. Bisogno, A. Ferrari, Raquel Dávila Fajardo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.